- Home
- CYTH vs FENG Comparison
CYTH vs FENG Comparison
Compare CYTH & FENG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYTH
- FENG
- Stock Information
- Founded
- CYTH 1990
- FENG 1998
- Country
- CYTH United States
- FENG China
- Employees
- CYTH N/A
- FENG N/A
- Industry
- CYTH Biotechnology: Pharmaceutical Preparations
- FENG Broadcasting
- Sector
- CYTH Health Care
- FENG Industrials
- Exchange
- CYTH Nasdaq
- FENG Nasdaq
- Market Cap
- CYTH 26.2M
- FENG 26.5M
- IPO Year
- CYTH N/A
- FENG 2011
- Fundamental
- Price
- CYTH $0.76
- FENG $2.21
- Analyst Decision
- CYTH Buy
- FENG
- Analyst Count
- CYTH 3
- FENG 0
- Target Price
- CYTH $0.95
- FENG N/A
- AVG Volume (30 Days)
- CYTH 44.3K
- FENG 6.5K
- Earning Date
- CYTH 03-17-2025
- FENG 03-11-2025
- Dividend Yield
- CYTH N/A
- FENG N/A
- EPS Growth
- CYTH N/A
- FENG N/A
- EPS
- CYTH N/A
- FENG N/A
- Revenue
- CYTH $870,725.00
- FENG $99,426,474.00
- Revenue This Year
- CYTH N/A
- FENG N/A
- Revenue Next Year
- CYTH $24.49
- FENG N/A
- P/E Ratio
- CYTH N/A
- FENG N/A
- Revenue Growth
- CYTH N/A
- FENG N/A
- 52 Week Low
- CYTH $0.55
- FENG $1.20
- 52 Week High
- CYTH $1.92
- FENG $4.15
- Technical
- Relative Strength Index (RSI)
- CYTH 54.14
- FENG 41.28
- Support Level
- CYTH $0.70
- FENG $2.11
- Resistance Level
- CYTH $0.87
- FENG $2.33
- Average True Range (ATR)
- CYTH 0.07
- FENG 0.15
- MACD
- CYTH -0.00
- FENG -0.00
- Stochastic Oscillator
- CYTH 49.91
- FENG 44.00
About CYTH Cyclo Therapeutics Inc.
Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company is engaged in developing cyclodextrin-based products for treating neurodegenerative diseases, particularly Niemann-Pick Type C disease (NPC). The company's lead drug candidate, Trappsol Cyclo, has undergone clinical trials for NPC treatment. Operating in one segment, the company focuses on developing and commercializing cyclodextrin-based treatments for rare diseases. Revenue primarily comes from selling cyclodextrins and related products to pharmaceutical and nutritional industries, with Trappsol HPB and Trappsol Fine Chemical being significant contributors.
About FENG Phoenix New Media Limited
Phoenix New Media Ltd is a media company providing premium content on an integrated platform across the internet, mobile and TV channels in China. The company organizes its operations into two main segments: Net advertising services and Paid services. It provides its content and services through three channels: ifeng.com channel, video channel, and mobile channel. The company also offers a wide range of paid services including mobile value-added services, games, and content sales. It generates the majority of its revenue from Net advertising services. Geographically, it derives revenue from China.